In a groundbreaking achievement, Paul A. Negulescu from Vertex Pharmaceuticals and Tito Gonzalez from Integro Theranostics, both based in San Diego, have been honored with the prestigious 2025 Lasker Award for their remarkable contributions to the treatment of cystic fibrosis. This genetic disorder poses significant threats to individuals by causing severe damage to their organs. […]
Positron emission tomography (PET) stands as a vital diagnostic tool, utilizing radiopharmaceutical tracers to detect diseases like cancer and brain disorders. At Jagiellonian University, Paweł Moskal and his team are pioneering a groundbreaking PET scanner, the J-PET, which delves into imaging the properties of positronium, offering a new dimension to PET diagnoses. Positronium, a short-lived […]
Dean Pepol has been intimately acquainted with the challenges of prostate cancer, a disease that ranks as the second-leading cause of cancer-related deaths among American men. His family history of prostate cancer, including his father’s diagnosis, prompted Pepol to diligently monitor his prostate-specific antigen (PSA) levels through regular physical exams. In 2006, Pepol received unsettling […]
Sarvodaya Hospital in Faridabad has become India’s first Theranostics Center to offer Terbium-161 PSMA therapy for advanced prostate cancer patients. In addition to this groundbreaking therapy, the hospital now provides CAR-T Cell therapy, an advanced treatment for blood cancers like leukemia, lymphoma, and multiple myeloma, making it a one-stop destination for comprehensive cancer care. Dr. […]
